KFF Health News1d
Purdue Pharma, Sacklers Unveil New Settlement For OxyContin Lawsuits
The plan put forth Tuesday could see the Sackler family pay up to $7 billion. Also in the news: Merck prepares to close its manufacturing plant in Pennsylvania; Optum Rx, which includes UnitedHealth ...
KFF Health News1d
From KFF Health News - Latest Stories:
“Health Minute” brings original health care and health policy reporting from the KFF Health News newsroom to the airwaves each week. (3/18) Here's today's health policy haiku: ...
High-resolution images capture intricate structure of mitochondrial supercomplexes
Mitochondria are the powerhouses in our cells, producing the energy for all vital processes. Using cryo-electron tomography, ...
Fierce Pharma3d
Dr. Reddy’s, Sun Pharma and Zydus issue US recalls, citing failed specs and labeling issues
The companies in question, Dr. Reddy’s Laboratories, Sun Pharma and Zydus Pharmaceuticals, are recalling seizure treatments, ...
The Financial Express6d
Complan grows up, Zydus takes kids’ health drink into adult’s wellness market
Zydus Wellness, which acquired Complan in 2019, is rewriting the playbook—expanding the brand beyond kids, tapping into digital commerce, and leveraging scientific credibility to solidify its ...
Zydus Lifesciences shares in focus after FDA approval for prostate cancer drug
Zydus Lifesciences received final USFDA approval to manufacture Apalutamide tablets for prostate cancer, following last ...
TipRanks on MSN4d
Zydus Lifesciences Gains USFDA Approval for Eluxadoline Tablets
Zydus Lifesciences Limited ( ($IN:ZYDUSLIFE) ) has shared an update. Zydus Lifesciences Limited has received final approval from the USFDA to ...
Business Today3d
Stock market today: Nifty levels to watch; trading views on Dr Reddys Labs, Cipla & Zydus Life
Zydus Life has breached the critical Rs 910 level, a zone that previously attracted significant buying interest and fueled the rally to its all-time high. A closer analysis reveals the formation ...
Business Line6d
Indian pharma ramps up US acquisitions amid regulatory and market shifts
Leading players like Sun Pharma, Syngene, Senores, and Zydus have all made strategic purchases ... the rising demand for biosimilars and specialty drugs has also encouraged acquisitions, as ...
Business Standard4d
Sun Pharma, Zydus recall medicines in US over quality concerns: USFDA
Sun Pharma and Zydus Pharmaceuticals are recalling products in the US market ... Indian pharmaceutical companies supply a substantial proportion of drugs to US residents, with four out of ten of all ...
Pharmerging Market Expected To Achieve A Strong 9.32% CAGR, To Reach USD 875.43 Billion By 2034
Pharmerging Market Pharmerging Market Poised for Rapid Growth Amid Rising Healthcare Demands US, NY, UNITED STATES, March 15, 2025 /EIN ...
cnbctv184d
Sun Pharma, Zydus Pharma recall drugs in US over quality concerns
Indian pharmaceutical giants Sun Pharma and Zydus Pharmaceuticals are recalling certain products from the US market due to manufacturing concerns, according to the latest Enforcement Report from the ...